Popular culture often equates testosterone with virility, strength, and the macho male physique. Viewed by some as an a /antiaging tonic,a testosteronea (TM)s reputation and increased use by men of all ages in the United States have outpaced the scientific evidence about its potential benefits and risks. In particular there has been growing concern about an increase in the number of middle-aged and older men using testosterone and the lack of scientific data on the effect it may have on aging males. Studies of testosterone replacement therapy in older men have generally been of short duration, involving small numbers of participants and often lacking adequate controls. Testosterone and Aging weighs the options of future research directions, examines the risks and benefits of testosterone replacement therapy, assesses the potential public health impact of such therapy in the United States, and considers ethical issues related to the conduct of clinical trials. Testosterone therapy remains an attractive option to many men even as speculation abounds regarding its potential.
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
Institute of Medicine, Board on Health Sciences Policy, Committee on the Public Health Dimensions of Cognitive Aging, Catharyn T. Liverman, Kristine Yaffe, Dan G. Blazer
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Sciences Policy, Committee on Accessible and Affordable Hearing Health Care for Adults, Catharyn T. Liverman, Sarah Domnitz, Dan G. Blazer
Institute of Medicine, Board on Health Sciences Policy, and Genetic Factors in Health Committee on Assessing Interactions Among Social, Behavioral, Dan G. Blazer, Lyla M. Hernandez
Institute of Medicine, Board on Health Sciences Policy, Committee to Review the Clinical and Translational Science Awards Program at the National Center for Advancing Translational Sciences, Catharyn T. Liverman, Andrea M. Schultz, Sharon F. Terry, Alan I. Leshner